Applied Industrial Technologies Inc: Form 10-Q for the period ended Mar 31, 2024
Filed with the SEC on Apr 26, 2024 and accepted by EDGAR at Apr 26, 2024, 12:13 ET.
Management's discussion and analysis
As filed, 1,076 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Repurchases of common stock in the quarter ended March 31, 2024 were as follows:
| Period | (a) Total Number of Shares | (b) Average Price Paid per Share ($) | (c) Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs | (d) Maximum Number of Shares that May Yet Be Purchased Under the Plans or Programs (1) |
|---|---|---|---|---|
| January 1, 2024 to January 31, 2024 | 37,053 | $168.18 | 37,053 | 1,400,000 |
| February 1, 2024 to February 29, 2024 | 0 | $0.00 | 0 | 1,400,000 |
| March 1, 2024 to March 31, 2024 | 63,000 | $189.96 | 63,000 | 1,337,000 |
| Total | 100,053 | $181.89 | 100,053 | 1,337,000 |
(1) On August 9, 2022, the Board of Directors authorized the repurchase of up to 1.5 million shares of the Company's common stock, replacing the prior authorization. We publicly announced the new authorization on August 11, 2022. Purchases can be made in the open market or in privately negotiated transactions. The authorization is in effect until all shares are purchased, or the Board revokes or amends the authorization.
Market risk
As filed, 204 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
For quantitative and qualitative disclosures about market risk, see Item 7A "Quantitative and Qualitative Disclosures About Market Risk" in our Annual Report on Form 10-K for the year ended June 30, 2023.
Controls and procedures
As filed, 816 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Evaluation of Disclosure Controls and Procedures
The Company's management, under the supervision and with the participation of the Chief Executive Officer (CEO) and Chief Financial Officer (CFO), evaluated the effectiveness of the Company's disclosure controls and procedures, as defined in Exchange Act Rule 13a-15(e), as of the end of the period covered by this report. Based on that evaluation, the CEO and CFO have concluded that the Company's disclosure controls and procedures are effective.
Changes in Internal Control Over Financial Reporting
There have not been any changes in internal control over financial reporting during the three months ended March 31, 2024 that have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2024-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2024-01-01 to 2024-03-31 | $1.15bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2023-07-01 to 2024-03-31 | $3.32bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2024-01-01 to 2024-03-31 | $808.1m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2023-07-01 to 2024-03-31 | $2.34bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2024-01-01 to 2024-03-31 | $338.2m | us-gaap:GrossProfit |
| Gross profit | 9 months2023-07-01 to 2024-03-31 | $980.4m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months2024-01-01 to 2024-03-31 | $217.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2023-07-01 to 2024-03-31 | $623.9m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2024-01-01 to 2024-03-31 | $121.2m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2023-07-01 to 2024-03-31 | $356.5m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2024-01-01 to 2024-03-31 | $25.4m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2023-07-01 to 2024-03-31 | $74.9m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2024-01-01 to 2024-03-31 | $97.2m | us-gaap:NetIncomeLoss |
| Net income | 9 months2023-07-01 to 2024-03-31 | $282.3m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2024-01-01 to 2024-03-31 | $2.48 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2023-07-01 to 2024-03-31 | $7.18 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2024-01-01 to 2024-03-31 | $2.51 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2023-07-01 to 2024-03-31 | $7.29 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2024-01-01 to 2024-03-31 | 39,252,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2023-07-01 to 2024-03-31 | 39,291,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2023-07-01 to 2024-03-31 | $252.2m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2024-01-01 to 2024-03-31 | $7.5m | us-gaap:PaymentsToAcquireProductiveAssets |
| Capital expenditure | 9 months2023-07-01 to 2024-03-31 | $17.4m | us-gaap:PaymentsToAcquireProductiveAssets |
| Dividends paid | 9 months2023-07-01 to 2024-03-31 | $41.5m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 9 months2023-07-01 to 2024-03-31 | $28.9m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Current assets | At period end2024-03-31 | $1.77bn | us-gaap:AssetsCurrent |
| Total assets | At period end2024-03-31 | $2.85bn | us-gaap:Assets |
| Current liabilities | At period end2024-03-31 | $468.4m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2024-03-31 | $1.19bn | us-gaap:Liabilities |
| Long-term debt | At period end2024-03-31 | $571.9m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2024-03-31 | $25.1m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2024-03-31 | $1.67bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000109563-24-000033. Last ingested by Listed: Oct 27, 2026, 21:29 ET. Listed shows no prices and gives no investment advice.